(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
|
|
(Address of principal executive offices) |
(Zip code) |
Large accelerated filer ☐
|
|
Accelerated filer ☐
|
Smaller reporting company
|
|
Emerging growth company
|
As of November 21, 2022, the registrant had
GLOBAL ARENA HOLDING, INC.
TABLE OF CONTENTS
|
|
|
Item 1. Financial Statements
|
3
|
|
4
|
||
5
|
||
6
|
||
8
|
||
9
|
||
26
|
||
32
|
||
32
|
34
|
||
34 |
||
34 |
||
35 |
||
35 |
||
35 |
||
35 |
||
35
|
September 30,
2022 |
December 31,
2021 |
|||||||
|
(unaudited)
|
|
||||||
ASSETS
|
||||||||
Current Assets:
|
||||||||
Cash and cash equivalents
|
$ | $ | ||||||
Total current assets
|
||||||||
|
||||||||
Deposits for proposed acquisitions
|
||||||||
TOTAL ASSETS
|
$ | $ | ||||||
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
Current Liabilities:
|
||||||||
Accounts payable
|
$ | $ | ||||||
Accrued expenses
|
||||||||
Convertible promissory notes payable,
|
||||||||
net of debt discount of $
|
||||||||
Promissory notes payable
|
||||||||
Deferred revenue
|
||||||||
Derivative liability
|
||||||||
Total current liabilities
|
||||||||
|
||||||||
STOCKHOLDERS' DEFICIT
|
||||||||
Global Arena Holdings, Inc.
|
||||||||
Preferred stock, $
authorized;
|
||||||||
Series B preferred stock;
|
||||||||
|
||||||||
Series C preferred stock; |
||||||||
|
|
|
||||||
Common stock, $
|
||||||||
|
||||||||
Additional paid-in capital
|
||||||||
Accumulated deficit
|
( |
) | ( |
) | ||||
Total Global Arena Holdings, Inc. stockholders’ deficit
|
( |
) | ( |
) | ||||
Noncontrolling interest
|
( |
) | ( |
) | ||||
Total stockholders’ deficit
|
( |
) | ( |
) | ||||
TOTAL LIABILITIES AND STOCKHOLDERS'
DEFICIT
|
$ |
$ |
|
Three Months Ended September 30,
|
Nine Months Ended September 30, |
||||||||||||||
2022
|
2021
|
2022 |
2021 |
|||||||||||||
Revenues:
|
||||||||||||||||
Services
|
$ | $ |
$ |
|
$ |
|
||||||||||
Operating expenses:
|
||||||||||||||||
Salaries and benefits
|
|
|
||||||||||||||
Marketing and advertising
|
|
|||||||||||||||
Software development
|
|
|
||||||||||||||
Professional fees
|
|
|
||||||||||||||
General and administrative
|
|
|
||||||||||||||
Printing
|
|
|
||||||||||||||
Total operating expenses
|
|
|
||||||||||||||
Loss from operations
|
( |
) | ( |
) |
( |
) | ( |
) | ||||||||
Other expenses:
|
||||||||||||||||
Interest expense and financing costs
|
( |
) | ( |
) |
( |
) | ( |
) | ||||||||
Debt Forgiveness |
|
|
||||||||||||||
Change in fair value of derivative liability
|
|
( |
) | |||||||||||||
Gain on settlement of debt
|
|
|||||||||||||||
Total other expenses
|
( |
) | ( |
) | ( |
) | ||||||||||
Income (loss) before provision for taxes
|
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Provision for income taxes
|
||||||||||||||||
Net loss
|
( |
) | ( |
) |
( |
) | ( |
) | ||||||||
Net loss attributed to noncontrolling interest
|
||||||||||||||||
Net loss attributed to Global Arena Holding, Inc.
|
$ | ( |
) | $ | ( |
) |
$ |
( |
) |
$ |
( |
) | ||||
Weighted average shares outstanding - basic and diluted
|
|
|
||||||||||||||
Earnings (loss) per share - basic and diluted
|
$ | ( |
) | $ | ( |
) |
$ |
( |
) |
$ |
( |
) | ||||
$ | ( |
) | $ | ( |
) |
$ |
( |
) |
$ |
( |
) |
Series B Preferred Stock |
Series C Preferred Stock |
Common Stock |
Additional Paid-in |
Accumulated |
Total Global Stockholders' |
Noncontrolling |
Total Stockholders’ |
||||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
Interest |
Deficit |
|||||||||||||||||||||||||||||||||||
Balance, December 31, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
|||||||||||||||||||||||||
Issuance of common stock for convertible debt and accrued interest |
|
|
|
- |
|
|
|||||||||||||||||||||||||||||||||||||||
Allocated value of warrants and beneficial conversion feature related to issuance of convertible debt |
|
- |
|
|
|||||||||||||||||||||||||||||||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | |||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2022 |
|
|
|
|
|
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||
Issuance of common stock for convertible debt and accrued interest |
|
|
( |
) |
|
|
|||||||||||||||||||||||||||||||||||||||
Allocated value of warrants and beneficial conversion feature related to issuance of convertible debt |
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | |||||||||||||||||||||||||||||||||||||||
Balance, June 30, 2022 |
|
$ |
|
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
||||||||||||||||||||||||
Issuance of common stock for convertible debt and accrued interest |
|
|
( |
) |
|
|
|||||||||||||||||||||||||||||||||||||||
Issuance of common stock for Series C Preferred Stock |
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Conversion of warrants |
|
|
( |
) |
|
|
|||||||||||||||||||||||||||||||||||||||
Allocated value of warrants and beneficial conversion |
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Net loss |
( |
) |
( |
) |
( |
) |
|||||||||||||||||||||||||||||||||||||||
Balance, September 30, 2022 |
|
$ |
|
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
GLOBAL ARENA HOLDING, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (continued)
Series B Preferred Stock |
Series C Preferred Stock |
Common Stock |
Additional Paid-in |
Accumulated |
Total Global Stockholders' |
Noncontrolling |
Total Stockholders’ |
|||||||||||||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
Shares |
Amount |
Capital |
Deficit |
Deficit |
Interest |
Deficit |
||||||||||||||||||||||||||||||||||
Balance, December 31, 2020 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
||||||||||||||||||||||||
Issuance of common stock for convertible debt and accrued interest |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Issuance of common stock for debt settlement |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Allocated value of warrants and beneficial conversion feature related to issuance of convertible debt |
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||
Balance, March 31, 2021 |
|
|
|
|
|
( |
) |
( |
) |
( |
) |
( |
) |
|||||||||||||||||||||||||||||||
Allocated value of warrants and beneficial conversion feature related to issuance of convertible debt |
|
|
|
|
||||||||||||||||||||||||||||||||||||||||
Net loss |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||||||||
Balance, June 30, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
||||||||||||||||||||||||
Cashless exercise of warrants |
|
|
( |
) |
||||||||||||||||||||||||||||||||||||||||
Allocated value of warrants and beneficial conversion feature related to issuance of convertible debt |
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Net loss |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||||
Balance, September 30, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
7
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)
|
Nine Months Ended September 30,
|
|||||||
2022
|
2021
|
|||||||
OPERATING ACTIVITIES:
|
||||||||
Net loss
|
$ | ( |
) | $ | ( |
) | ||
Adjustments to reconcile net loss to
|
||||||||
net cash used in operating activities: |
||||||||
Amortization of debt discount
|
||||||||
Change in fair value of derivative liability
|
( |
) | ||||||
Gain on settlement of debt
|
( |
) | ||||||
Change in assets and liabilities:
|
||||||||
Deferred revenue
|
( |
) | ( |
) | ||||
Accounts payable
|
( |
) | ( |
) | ||||
Accrued expenses
|
||||||||
Net cash used in operating activities
|
( |
) | ( |
) | ||||
INVESTING ACTIVITIES: |
||||||||
Payment of deposit for acquisition | ( |
) | ||||||
Net cash used in investing activities | ( |
) | ||||||
FINANCING ACTIVITIES:
|
||||||||
Proceeds from convertible promissory notes payable
|
||||||||
Proceeds from note payable | ||||||||
Repayment of note payable | ( |
) | ||||||
Repayment of convertible promissory notes payable
|
( |
) | ( |
) |
||||
Net cash used in financing activities
|
||||||||
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
( |
) | ( |
) | ||||
|
||||||||
CASH AND CASH EQUIVALENTS, BEGINNING BALANCE
|
||||||||
|
||||||||
CASH AND CASH EQUIVALENTS, ENDING BALANCE
|
$ | $ | ||||||
CASH PAID FOR:
|
||||||||
Interest
|
$ | $ | ||||||
Income taxes
|
$ | $ | ||||||
NON-CASH INVESTING AND FINANCING ACTIVITIES:
|
||||||||
Allocated value of warrants and beneficial conversion features related to debt
|
$ |